Dapirolizumab

Product Description: Dapirolizumab is a monoclonal antibodi against CD40 ligand. Dapirolizumab targets CD40L, blocks its interaction with CD40 receptors, and inhibits adaptive immune activation. Dapirolizumab attenuates systemic lupus erythematosus[1].

Formula: N/A

References: [1]Furie RA, et al., Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. Rheumatology (Oxford). 2021 Nov 3;60(11):5397-5407.

Molecular Weight: N/A

Compound Purity: 99.24

Research Area: Inflammation/Immunology

Target: TNF Receptor

• SKU: MEXHY-P99842A-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99842A-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated